- Home
- VSCO vs LGND Comparison
VSCO vs LGND Comparison
Compare VSCO & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSCO
- LGND
- Stock Information
- Founded
- VSCO 1977
- LGND 1987
- Country
- VSCO United States
- LGND United States
- Employees
- VSCO N/A
- LGND N/A
- Industry
- VSCO Clothing/Shoe/Accessory Stores
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- VSCO Consumer Discretionary
- LGND Health Care
- Exchange
- VSCO Nasdaq
- LGND Nasdaq
- Market Cap
- VSCO 2.2B
- LGND 2.3B
- IPO Year
- VSCO N/A
- LGND 1992
- Fundamental
- Price
- VSCO $41.94
- LGND $119.93
- Analyst Decision
- VSCO Hold
- LGND Strong Buy
- Analyst Count
- VSCO 11
- LGND 6
- Target Price
- VSCO $26.73
- LGND $144.83
- AVG Volume (30 Days)
- VSCO 2.0M
- LGND 137.1K
- Earning Date
- VSCO 12-05-2024
- LGND 11-07-2024
- Dividend Yield
- VSCO N/A
- LGND N/A
- EPS Growth
- VSCO N/A
- LGND 160.46
- EPS
- VSCO 1.74
- LGND 2.47
- Revenue
- VSCO $6,125,000,000.00
- LGND $152,422,000.00
- Revenue This Year
- VSCO $0.66
- LGND $26.86
- Revenue Next Year
- VSCO $1.12
- LGND $13.16
- P/E Ratio
- VSCO $24.10
- LGND $48.52
- Revenue Growth
- VSCO N/A
- LGND N/A
- 52 Week Low
- VSCO $15.12
- LGND $58.97
- 52 Week High
- VSCO $42.95
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- VSCO 83.02
- LGND 55.34
- Support Level
- VSCO $36.18
- LGND $119.18
- Resistance Level
- VSCO $42.95
- LGND $125.00
- Average True Range (ATR)
- VSCO 1.64
- LGND 4.56
- MACD
- VSCO 0.29
- LGND 0.07
- Stochastic Oscillator
- VSCO 88.05
- LGND 64.28
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime. The Company operates as a single segment designed to serve customers worldwide seamlessly through stores and online channels.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.